text:
Tuesday 09 February, 2016 Updated 2:25
27 Jul 2013
Views: 1,188
Font Size:
a /
Youths on community watch mission
The fresh security challenges that have emerged in parts of the country since President Goodluck Jonathan declared state of emergency in three northern states of Adamawa, Borno and Yobe are, to me, wake up calls to the governments at all levels to return to the drawing boards and come out with measures that will serve as plan 'B' in our determined effort to arrest insurgency in the country.
One of the options, in my view, is the need to revive the concept of community policing in all parts of the country and drape it with quasi-powers for it to succeed. Here, I am not advocating for a state police. I am indeed rooting for what I may call neighbourhood watch. This system has proven to be pleasantly effective in areas that it has been put to use. Irrespective of whatever nomenclature it might assume, the fact is that it comes with some measure of deterrence that is weighty enough to ward off potential danger from befalling the community.
I recall vividly as a teenager growing up in the village in the 1980s how our traditional ruler and his chiefs had, as matter of necessity, put in place a semblance of community policing in his domain to check the rising cases of "petty thieves"; those that specialised in breaking barns to steal some tubers of yam and yam seedlings in some case, breaking and entering into homes and carting away goats tied in the 'manger', among other valuables. The rate of the recurrence of the act got to an intolerable point when it was gathered that most of the perpetrators of the act were non-indigenes but with active connivance with few bad eggs living within.
So the challenge was: "what was the way out?" It was then resolved that a vigilante be put in place to check the menace. Under the arrangement, married women were dissolved into groups and were charged with the responsibility of policing the neighbourhoods from dawn-to-dusk. In the same vein, all married men as well as the mature bachelors were made to form security cells; which were deployed, in rotation, to neighbourhoods watch at nights beginning from 10pm till dawn.
The results were outstandingly unbelievable. Not only did the incidence of crime and other crime-related acts stamped out, it also recreated an atmosphere of absolute order in the community. Over two decades later, the thoughts and echoes of a saner neighbourhood returned to the indigenes that the group was reinvigorated, but this time, with fresh impetus by all to rise against vices that had continually denied the residents of the village well-deserved sleep or that which continued to create fear in them. The return of the security watch group also came with radical policies that killed some age-long traditional practices like the proscription of wake-keeps, night parties, late interments, night funeral rites, among others. I can state here that the success rate has been awesome.
It must, however, be stated that community policing is not an end in itself, but a means to an end. Given the security challenges we are facing at the moment as a nation, I strongly believe that this option, if revisited and treated as an official policy, has the potential to reduce crime, fear and ultimately create a sense of order in our society. Under this arrangement, bonding among citizens is fostered and it can also serve as a veritable intelligence gathering channel for the law enforcement agencies.
If you are still in doubt about the beauty of this, check out the gains already recorded by the Civilian JTF in Maiduguri; check out the recent bravery of some folks that gave the intelligence at Ifo, Ogun State that led to the arrest of a fleeing Boko Haram member. Similar feat was recorded in a village in Kaduna State recently.
In the Ifo feat, a 22-year-old suspected Boko Haram member, Mallam Giraima Umaru Suri, from Bulunkutu Kasuwa area of Maiduguri was arrested in Abeokuta during the week. The Ogun State Police Command, which disclosed the arrest said that intelligent reports had facilitated the arrest of the suspect whom it said had confessed to being a member of the sect at Ishari Kara Cattle Market in Ifo Local Government Area of the state.
The suspect was reported to have confessed to have fled Maiduguri to the state due to the manhunt placed on members of the sect by security operatives was picked up by police operatives in the state, following a tip off.
Tired of the menace of the insurgents in their communities, the Borno Civilian JTF (CJTF) said they had to rise to the occasion by massively contributing to the enforcement of security in the Maiduguri metropolis.
The youths said they know the Boko Haram members who lived in their midst in the past and those still living, but lacked the courage to reveal their identity for fear of being killed. The CJTF members took it upon themselves to help the authorities to uproot the murderous Boko Haram members from the metropolis by going round the city, identifying run away suspected terrorists, arresting them and handing them over to the military-led joint military task force.
In Kaduna, it was also a pay-back time for some gunmen who invaded a village near Fadan Kaje in Zango Kataf Local Government Area of Kaduna State, as they were overpowered by hundreds of villagers, who killed two of them, while the rest fled. The gunmen were said to have arrived at Madauchi village at the wee-hour of the night and invaded the residence of a prominent villager with the intention of stealing cows.
In many advanced democracies, law enforcement officers, as public servants who interact with citizens on a daily basis, have a unique opportunity to demonstrate the importance of citizen involvement in the community. In turn, they realise that their authority and effectiveness are linked directly to the support they receive from citizens. When fully embraced, community policing is democracy at its best.
Den of car snatchers…
• Gudi
• Keffi Road
• Asakio in Nasarawa East Devt Area
• Agyaragu in Obi Local Govt Area
• Nasarawa Eggon Hills
• Nasarawa Toto
• Karu
Source: State police command
Lagos State
• Commissioner of Police: 08034752664
• PPRO: 08033027142 ; 08125151603; and 08115557885
• Control Rooms: 08080499797; 08123405164; 08037332678; 08037034711; 08080499797; 08063299264; 08060357795; 08079279349; 080755462708; 07035068242; and 07055068242
Bayelsa State
*Commissioner of Police: 08035045847
Kaduna State
• Commissioner of Police: 08033008525
• Operation Yaki: 08081708671, 08160005000, 08160000030, 08160002000, and 08160000045
Ondo State
• Commissioner of Police: 08081774646 and 08033429440
• O/C Operation: 08034072740
Ekiti State
• Commissioner of Police: 08037003030
• PPRO: 08056022366 and 08125275109
Ogun State
• Police Distress Call lines
08032136765; 08037168147; 08123822910; and 08081771717
• Email: email@example.com
Kogi State
• Command Hqtrs: O7030704642
Bauchi State
• Commissioner of Police: 08035324090, 08126281692;
Abia State
• Commissioner of Police: 08032862623
Emergency numbers (24 hours)
• 08079210003
• 08079210004
• 08079210005
Ebonyi State
• Commissioner of Police: 08033145629
C/River State
• Commissioner of Police: 08033027978
Toyota Matrix AGL 19AX Festac Div
Range Rover Jeep KJA 54 BK Dopemu Div
Toyota Corolla FB 838 LSR Sango Ota Div
Toyota Prado Jeep Unregistered Sango Ota Div
Nissan Sunny JA 133 ABC Shasha Div
Volkswagen Golf 3 SR 648 SMK Man Centre
V/W Vanagon Bus XM 114 JJJ Layeni Div
Toyota Matrix LND 582 BB Onipanu Div
Honda Accord HU 89 AAA Ijeshatedo Div
Nissan Pathfinder FST 222 AR Morogbo Div
Honda Accord CQ 577 APP Sabo Div
Toyota Camry KRD 464 AX Amukoko Div
Tags: Life and Style, Youth, community watch
Comments: 0
Read more...
09 Feb 2016
Please leave your comment below. Your name will appear next to your comment. We'll also keep you updated by email whenever someone else comments on this page. Your comment will appear on this page once it has been approved by a moderator.
Forgotten your Password?
Please enter some keywords that you'd like to search for. Your results will be displayed below.
08 Feb 2016
07 Feb 2016
THISDAYLIVE cares about you, help us to report better!
Please wait...


text:
Quotes & Info
|ARIA > SEC Filings for ARIA > Form 10-Q on 9-Nov-2012
|All Recent SEC Filings
Quarterly Report
The information set forth below should be read in conjunction with our unaudited condensed consolidated financial statements and the notes thereto included herein, as well as our audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2011. Unless stated otherwise, references in this Quarterly Report on Form 10-Q to "we," "us," or "our" refer to ARIAD Pharmaceuticals, Inc., a Delaware corporation, and our subsidiaries unless the context requires otherwise.
Our vision is to transform the lives of cancer patients with breakthrough medicines. Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest and most urgent unmet medical need - aggressive cancers where current therapies are inadequate. Our goal is to build a fully integrated oncology company focused on novel, molecularly targeted therapies to treat solid tumors and hematologic cancers.
Regulatory Process and Commercialization
In July 2012, we filed for regulatory approval in the United States of our lead product candidate, ponatinib, to treat patients with resistant or intolerant chronic myeloid leukemia, or CML, and Philadelphia - chromosome positive acute lymphoblastic leukemia, or Ph+ALL. We completed our rolling submission in September 2012. The U.S. Food and Drug Administration, or FDA, has granted priority review of this application and has established an action date of March 27, 2013 under the Prescription Drug User Fee Act, or PDUFA. We expect potential regulatory approval in the first quarter of 2013. In addition, in August 2012, we filed for marketing approval for ponatinib with the European Medicines Agency, or EMA, and expect potential approval in mid-2013. Subject to obtaining regulatory approval of ponatinib, we intend to commercialize ponatinib on our own in the United States, Europe and other selected territories worldwide. The FDA and the EMA are currently reviewing our applications, which reviews include, among other things, a detailed review of the data and information included in the applications, meetings and frequent communications between us and the regulatory authorities, and inspections, including potential inspections of clinical trial sites and third-party facilities used to manufacture ponatinib. If applicable regulatory criteria are not met, the regulatory authorities could refuse to approve or delay the approval of ponatinib.
If we are successful in obtaining approval of ponatinib in the United States in the anticipated time frames, we expect to begin marketing ponatinib shortly thereafter. Successful commercialization of ponatinib if it is approved will require effective marketing, distribution and pricing strategies; infrastructure to support commercial sales; sustained levels of drug product inventory of ponatinib; and company-wide processes and systems to support compliance with applicable laws and regulations and post-marketing safety evaluations. Our commercial leadership team has been preparing for anticipated commercial launch of ponatinib, including the hiring of a sales force and other professional staff necessary for an effective launch, the implementations of systems and processes to support launch, the development of tools and materials to be utilized during the commercialization of ponatinib and other activities.
We have also initiated operations in Europe, with headquarters in Switzerland, in preparation for potential EMA approval of ponatinib in mid-2013. We are hiring management and other personnel in key functions in Switzerland who are building our business infrastructure and capabilities in Europe. We plan to hire country-level personnel in key markets throughout Europe to focus on local market approvals, preparing for the launch of ponatinib upon approval and then managing marketing, sales and distribution operations.
As a result, our operating expenses have increased throughout 2012, as we prepare for anticipated regulatory approvals of ponatinib, and we expect that such expenses will continue to increase to support an effective launch of this product in various territories. In addition, we expect that our operating expenses will also continue to increase as we continue to expand our research and development activities for ponatinib and other product candidates discussed below.
Product Development and Discovery
Our product pipeline currently consists of three product candidates - ponatinib, AP26113 and ridaforolimus.
Ponatinib is an investigational pan BCR-ABL inhibitor that we believe has potential applications in various hematological cancers and solid tumors. In the third quarter of 2011, we completed patient enrollment in a pivotal Phase 2 clinical trial of ponatinib, which we refer to as the PACE trial, in approximately 450 patients with resistant or intolerant chronic myeloid leukemia, or CML, or Philadelphia positive acute lymphoblastic leukemia, or Ph+ ALL, who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation. In June 2012, we announced updated clinical data from the PACE trial that showed that 54% of chronic-phase CML patients in the trial, including 70% of patients who have a T315I mutation, achieved a major cytogenetic response. The most common adverse events considered related to ponatinib included thrombocytopenia, rash, dry skin, abdominal pain, and headache.
In July 2012, we initiated a randomized Phase 3 clinical trial of ponatinib, referred to as the EPIC trial, in adult patients with newly diagnosed CML in the chronic phase. The trial is designed to provide definitive clinical data to support regulatory approval of ponatinib in treatment-naďve CML. This trial is a randomized, two-arm, multi-center trial that compares the efficacy of ponatinib with that of imatinib. Approximately 500 patients will be enrolled and randomized 1:1 to treatment with ponatinib or imatinib. The primary endpoint of the trial is major molecular response (MMR) rate at 12 months of treatment.
In August 2012, we initiated a multicenter Phase 1/2 clinical trial in Japan of ponatinib in Japanese patients with CML who have failed treatment with dasatinib or nilotinib or who have Ph+ALL and have failed prior treatment with tyrosine kinase inhibitors. This trial is designed to establish the recommended dose for ponatinib and confirm its anti-leukemic activity in Japanese patients. We expect that this trial should provide the incremental data needed for initial regulatory approval of ponatinib in Japan. The phase 1 portion of the trial is designed to determine the recommended dose for Japanese patients and is expected to enroll at least 12 patients. The phase 2 portion of the trial is expected to enroll 25 patients. The primary endpoint for chronic phase CML patients is major cytogenetic response. The primary endpoint for accelerated and blast phase CML patients and for Ph+ALL patients is major hematologic response.
We plan to initiate additional clinical trials of ponatinib as we continue development of this product candidate.
AP26113 is an investigational dual inhibitor of anaplastic lymphoma kinase, or ALK, and epidermal growth factor receptor, or EGFR - two clinically validated targets in non-small cell lung cancer, or NSCLC. We initiated patient enrollment in a Phase 1/2 clinical trial of AP26113 in the third quarter of 2011. We expect to enroll approximately 30 to 50 patients in the phase 1 portion of the trial and approximately 80 patients in the phase 2 portion of the trial.
In September 2012, we announced initial clinical results from the Phase 1/2 trial of AP26113. The primary objectives of the phase 1 portion of the trial are to determine the maximum tolerated dose and the recommended dose for further study of AP26113 and to characterize its safety and preliminary anti-tumor activity. At the time of the announcement, 34 patients had been enrolled in the study and 19 remained on study. Safety data to date showed AP26113 to be generally well tolerated. The most common adverse events were nausea and fatigue. Of the 11 ALK-positive patients evaluable for response, eight patients demonstrated a partial response, or PR, using RECIST criteria. Of the six patients with EGFR mutant NSCLC, all of whom had failed other treatments, one patient achieved a partial response and two patients had stable disease. Based on these initial clinical results, we have initiated planning for a pivotal trial of AP26113 in ALK-positive NSCLC patients to begin in 2013.
Ridaforolimus is an investigational mTOR inhibitor that we discovered internally and later licensed in 2010 to Merck & Co., Inc., or Merck. Under the license agreement, Merck is responsible for all activities and funds 100 percent of the costs related to the development, manufacturing and commercialization of ridaforolimus in oncology. In the third quarter of 2011, Merck filed in both Europe and the United States for regulatory approval of ridaforolimus as a maintenance therapy for patients with metastatic soft-tissue and bone sarcomas who had a favorable response to chemotherapy. In June 2012, the U.S. Food and Drug Administration, or FDA, issued a complete response letter regarding the New Drug Application, or NDA, filed by Merck, stating that the FDA cannot approve the application in its present form and that additional clinical trial(s) would need to be conducted to further assess safety and efficacy of ridaforolimus in this indication. Merck has announced that it is in ongoing discussions with health authorities in Europe and other countries as part of their application procedures for ridaforolimus for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy, and that Merck is studying ridaforolimus in combination with other mechanisms in several tumor types. Under the license agreement, Merck has agreed to pay us milestone payments based on successful development of ridaforolimus and achievement of specified sales thresholds, as well as tiered, double-digit royalties on global net sales of ridaforolimus.
In addition to our lead development programs, we have a focused drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer.
Critical Accounting Policies and Estimates
Our financial position and results of operations are affected by subjective and complex judgments, particularly in the areas of revenue recognition, the carrying value of intangible assets, accrued product development expenses, the fair value of warrants to purchase our common stock, and inventory valuation.
Revenue Recognition
We generate revenue from license and collaboration agreements with third parties related to use of our technology and/or development and commercialization of product candidates. Such agreements may provide for payment to us of up-front payments, periodic license payments, milestone payments and royalties. We also generate revenue from services provided under license agreements.
For the nine months ended September 30, 2012, we reported total licensing and service revenue of $484,000. Revenue is recognized when there is persuasive evidence that an arrangement exists, delivery has occurred, the price is fixed and determinable and collection is reasonably assured. Revenue arrangements with multiple elements are divided into separate units of accounting if certain criteria are met, including whether the delivered element has stand-alone value to the customer. When deliverables are separable, consideration received is allocated to the separate units of accounting based on the relative selling price of the elements and the appropriate revenue recognition principles are applied to each unit.
The assessment of multiple element arrangements requires judgment in order to determine the appropriate units of accounting and the points in time that, or periods over which, revenue should be recognized. Regarding our license agreement with Merck entered into in May 2010, the transition services are recognized in the period in which they are received or the services are rendered. Milestone payments under the license agreement are recognized when earned.
Intangible Assets
At September 30, 2012, we reported $1.0 million of intangible assets, consisting of capitalized costs related primarily to purchase and issued patents, patent applications and licenses, net of accumulated amortization. The carrying value of these intangible assets is evaluated for possible impairment, and losses are recorded when the evaluation indicates that the carrying value is not recoverable. This evaluation involves estimates of future net cash flows expected to be generated by the asset. Such estimates require judgment regarding future events and expected cash flows. Changes in these estimates, including decisions to discontinue using the technologies, could result in material changes to our balance sheet and charges to our statements of operations. If we were to abandon the ongoing development of the underlying product candidates or technologies or terminate our efforts to pursue collaborations or license agreements, or if our estimates of future net cash flows expected to be generated by the asset change, we may be required to write down or write off a portion of the carrying value of our intangible assets. In the nine month period ended September 30, 2012, we recorded charges of $4.8 million in our statement of operations to reflect impairment of the intangible assets associated with ridaforolimus following the decision by the FDA not to approve the NDA filed by Merck for ridaforolimus for the treatment of patients with soft-tissue and bone sarcomas.
Accrued Product Development Expenses
We accrue expenses for our product development activities based on our estimates of services performed or progress achieved pursuant to contracts and agreements with multiple vendors including research laboratories, contract manufacturers, contract research organizations and clinical sites. These estimates are recorded in research and development expenses in our statement of operations and are reflected in accrued product development expenses on our balance sheet. At September 30, 2012, we reported accrued product development expenses of $13.3 million on our balance sheet.
Our estimates of services performed or progress achieved are based on all available information we have from reports, correspondence and discussions with our vendors. Our estimates of accrued expenses based on such information require judgment. Actual costs may vary from such estimates. When such variances become known, we adjust our expenses accordingly.
Fair Value of Warrants
Warrants outstanding at December 31, 2011 to purchase 5,805,843 shares of our common stock, issued on February 25, 2009 in connection with a registered direct offering of our common stock, were classified as a derivative liability. Accordingly, the fair value of the warrants was recorded on our balance sheet as a liability, and such fair value was adjusted in each financial reporting period with the adjustment to fair value reflected in our consolidated statement of operations. At December 31, 2011, we reported a warrant liability of $58.6 million on our balance sheet.
During the three-month period ended March 31, 2012, all 5,805,843 warrants that were outstanding at December 31, 2011 were exercised for proceeds to us of approximately $12.5 million. Upon the exercise of these remaining warrants, the balance of the warrant liability and the proceeds received upon exercise were credited to stockholders' equity and the liability was eliminated.
The fair value of the warrants was determined using the Black-Scholes option valuation model. Fluctuations in the assumptions and factors used in the Black-Scholes model resulted in adjustments to the fair value of the warrants recorded on our balance sheet reflected through charges or credits in our statement of operations. The primary factor in the Black-Scholes model that impacted the fair value of the warrants was the market value of our common stock on the date of the valuation.
We have incurred significant costs related to the manufacturing of drug product as part of our ongoing research and development activities and production of drug product that would be available to support commercialization activities. We will begin to capitalize costs of inventory produced in preparation for commercial sale of ponatinib when it is considered to have a high probability of regulatory approval and the costs to manufacture the drug product are expected to be recoverable through drug product sales.
We have expensed all costs related to the manufacture of ponatinib to date because of the inherent risks associated with the development of a drug candidate, the uncertainty about the regulatory approval process and the lack of history for our company of regulatory approval of drug candidates. We expect that the majority of the costs of the initial commercial supply of ponatinib that will be available for product sales if we obtain approval will have already been expensed. Accordingly, we expect the manufacturing costs for ponatinib included in our cost of sales to initially be insignificant, as most of these costs will have been recorded as research and development expenses in prior periods, and to increase as we begin to sell inventory that is produced after we begin capitalizing ponatinib commercial inventory.
Results of Operations
For the three months ended September 30, 2012 and 2011
We recorded total revenue of $85,000 in the three-month period ended September 30, 2012, compared to $25.1 million in the corresponding period in 2011. Total revenue in 2012 consisted of license revenue pursuant to a license agreement related to our ARGENT technology in accordance with our revenue recognition policy. Total revenue in 2011 consisted primarily of a $25 million milestone payment received pursuant to our License Agreement with Merck. For the remainder of 2012, we expect to record limited licensing revenue and service revenue. We cannot predict the timing or amount of any future revenue under our license agreement with Merck.
Operating Expenses
Research and Development Expenses
Research and development expenses increased by $19.1 million, or 97 percent, to $38.8 million in the three-month period ended September 30, 2012, compared to $19.7 million in the corresponding period in 2011, as described in further detail below. The research and development process necessary to develop a pharmaceutical product for commercialization is subject to extensive regulation by numerous governmental authorities in the United States and other countries. This process typically takes years to complete and requires the expenditure of substantial resources. Current requirements include:
• preclinical toxicology, pharmacology and metabolism studies, as well as in vivo efficacy studies in relevant animal models of disease;
• manufacturing of drug product for preclinical studies and clinical trials and ultimately for commercial supply;
• submission of the results of preclinical studies and information regarding manufacturing and control and proposed clinical protocol to the U.S. Food and Drug Administration, or FDA, in an investigational new drug application or IND (or similar filings with regulatory agencies outside the United States);
• conduct of clinical trials designed to provide data and information regarding the safety and efficacy of the product candidate in humans; and
• submission of all the results of testing to the FDA in a new drug application, or NDA (or similar filings with regulatory agencies outside the United States).
Upon approval by the appropriate regulatory authorities, including in some countries approval of product pricing, we may commence commercial marketing and distribution of the product.
We group our research and development, or R&D, expenses into two major categories: direct external expenses and all other R&D expenses. Direct external expenses consist of costs of outside parties to conduct laboratory studies, to develop manufacturing processes and manufacture product candidates, to conduct and manage clinical trials and similar costs related to our clinical and preclinical studies. These costs are accumulated and tracked by product candidate. All other R&D expenses consist of costs to compensate personnel, to purchase lab supplies and services, to lease, operate and maintain our facility, equipment and overhead and similar costs of our research and development efforts. These costs apply to our clinical and preclinical candidates as well as our discovery research efforts. Direct external expenses are further categorized as costs for clinical programs and costs for preclinical programs. Preclinical programs include product candidates undergoing toxicology, pharmacology, metabolism and efficacy studies and manufacturing process development required before testing in humans can begin. Product candidates are designated as clinical programs once we have filed an IND with the FDA, or a similar filing with regulatory agencies outside the United States, for the purpose of commencing clinical trials in humans.
Our R&D expenses for the three-month period ended September 30, 2012, as compared to the corresponding period in 2011, were as follows:
Three months ended September 30, In thousands 2012 2011 Increase Direct external expenses: Clinical programs $ 19,914 $ 9,585 $ 10,329 Preclinical programs - - - All other R&D expenses 18,908 10,107 8,801 $ 38,822 $ 19,692 $ 19,130
In 2012, our clinical programs consisted of (i) ponatinib, our pan BCR-ABL inhibitor, for which we are conducting a pivotal Phase 2 clinical trial and other trials, and (ii) AP26113, our ALK and EGFR inhibitor for which we filed an IND in June 2011 and commenced a Phase 1/2 clinical trial in the third quarter of 2011.
Direct external expenses for ponatinib were $17.7 million in the three-month period ended September 30, 2012, an increase of $9.1 million as compared to the corresponding period in 2011. The increase is due to
increases in clinical trial costs of $6.2 million, contract manufacturing costs of $593,000, and supporting non-clinical costs of $2.4 million. Clinical trials costs increased primarily due to ongoing treatment of patients in our pivotal Phase 2 PACE clinical trial and increased enrollment and treatment of patients in our Phase 3 EPIC clinical trial in newly diagnosed CML patients, including purchases of the comparator drug, imatinib, for use in this trial, as well as costs related to initiation of a Phase 1/2 clinical trial of ponatinib in Japan, offset in part by a decrease in costs of our on-going Phase 1 clinical trial as treatment of patients and other activities in this trial have decreased over this time period. Contract manufacturing costs increased due primarily to the conduct of product and process development and qualification initiatives to support regulatory filings for this product candidate, as well as the production of ponatinib for use in our clinical trials and to provide for initial commercial supply in anticipation of potential regulatory approval of ponatinib. Supporting non-clinical costs increased due primarily to increased quality and stability studies and initiatives to develop and commercialize a companion diagnostic test to identify patients with the T315I mutation of the BCR-ABL gene. We collaborated with MolecularMD Corp. to establish this companion diagnostic test and MolecularMD Corp. had filed a PreMarketing Approval (PMA) application with the FDA. In September 2012, we and MolecularMD announced the voluntary withdrawal of the PMA following advice from the FDA that the FDA no longer considered this test to be a companion diagnostic test for ponatinib. We expect that our direct external expenses for ponatinib will increase in the fourth quarter of 2012 and into 2013 as we continue to treat more patients in our ongoing clinical trials, initiate additional clinical trials of this product candidate and conduct additional studies to support continued development of ponatinib.
Direct external expenses for AP26113 were $2.2 million in the three-month period ended September 30, 2012, an increase of $1.2 million as compared to the corresponding period in 2011. The increase in expenses for AP26113 was due primarily to costs of the Phase 1/2 clinical trial initiated in the third quarter of 2011, offset in part by the completion in 2011 of toxicology studies and product development initiatives required for filing of the IND. We expect that our direct external expenses for AP26113 will increase in the fourth quarter of 2012 and into 2013 as we continue to enroll patients in our on-going clinical trial of this product candidate and conduct additional studies to support continued development of AP26113.
All other R&D expenses increased by $8.8 million in the three-month period ended September 30, 2012, as compared to the corresponding period in 2011. This increase is primarily due to an increase in personnel costs of $4.5 million due primarily to an increase in number of employees to support expanding R&D activities, overall increase in compensation for existing employees, and an increase in recruiting costs; an increase in professional services of $1.8 million due primarily to initiatives to upgrade systems and technology used in our business; an increase in stock-based compensation expense of $1.0 million as a result of the impact of a significant increase in the market value of our common stock on the value of stock-based compensation awards in 2011 and 2012; an increase in rent expense of $1.1 million as a result of an amendment to our existing building lease and a new lease agreement for additional office space; and an increase in lab expenses of $279,000. We expect that all other R&D expenses will increase in the fourth quarter of 2012 and into 2013 to support the expanding development of ponatinib and AP26113 and our ongoing discovery research efforts.
The successful development of our product candidates is uncertain and subject to a number of risks. We cannot be certain that any of our product candidates will prove to be safe and effective or will meet all of the applicable regulatory requirements needed to receive and maintain marketing approval. Data from preclinical studies and clinical trials are susceptible to varying interpretations that could delay, limit or prevent regulatory approval. We, the FDA or other regulatory authorities may suspend clinical trials at any time if we or they believe that the patients participating in such trials are being exposed to unacceptable risks or if such regulatory agencies find deficiencies in the conduct of the trials or other problems with our products under development. Delays or rejections may be encountered based on additional . . .

subset: commoncrawl


text:
Man Threatens To Kill Customers At Springs 7-Eleven
Updated: 07/18/2015 - A fight at a Colorado Springs 7-Eleven escalated after one of the men involved threatened to kill everyone at the store.
Updated: 07/18/2015 - A fight at a Colorado Springs 7-Eleven escalated after one of the men involved threatened to kill everyone at the store.
Updated: 07/18/2015 - Road rage took a violent turn Friday night, after a fight between occupants in two vehicles ended in a stabbing.
Updated: 07/21/2015 - Three men have been arrested for the early morning murder of a 14-year-old boy.
Updated: 07/16/2015 - Pueblo police are searching for suspects accused of stealing cell phones from a Cricket Wireless Store.
Updated: 07/16/2015 - Police and deputies are investigating the deaths of a man and woman who were found in rural El Paso County.
Posted: 07/08/2015 - Woodland Park police are investigating a bank robbery.
Posted: 07/04/2015 - Pueblo police are searching for the suspect in a bar shooting early Saturday morning.
Posted: 07/03/2015 - A robbery suspect assaulted a store manager as he made his way out of the shop with stolen clothes.
Updated: 07/03/2015 - It has been four years since a Colorado Springs resident Debbie Heriford disappeared from her neighborhood.
Posted: 07/02/2015 - A convenience store clerk says she was accosted by a robber while trying to open the shop Thursday morning.
Posted: 06/26/2015 - An armed man robbed a Colorado Springs Dollar Tree late Thursday night.
Posted: 06/25/2015 - Police are searching for a man accused of robbing a local business in Colorado Springs.
Updated: 06/23/2015 - A faded orange, '70s model truck has emerged as the vehicle of interest in a series of shootings in northern Colorado.
Posted: 06/23/2015 - Police say three robberies spanning the last several weeks are all connected.
Posted: 06/23/2015 - Pueblo police are looking for whoever is behind two veterinarian clinic break-ins.
Updated: 06/24/2015 - Thanks to numerous tips from the public, police say they have arrested a bank robbery suspect.
Posted: 06/23/2015 - An armed robber got a way with cash Monday morning.
Posted: 06/21/2015 - A man is on the loose after walking into a local pizza place with a gun and demanding "all the money," according to a police report.
Posted: 06/20/2015 - A shooting in a Colorado Springs neighborhood remains under investigation.
Posted: 06/19/2015 - Pueblo police need the public's help finding a burglary suspect.
Updated: 06/18/2015 - Colorado Springs police say they are looking for who vandalized and broke into six or seven cars around midnight on Thursday.
Updated: 06/18/2015 - An armed robbery took place late Wednesday night at a business on the 3900 block of Palmer Park Blvd., according to the Colorado Springs Police Department.
Posted: 06/17/2015 - Springs police are searching for a bank robber.
Updated: 06/17/2015 - A shooting at a Colorado Springs apartment complex remains under investigation.
Posted: 06/15/2015 - A robbery suspect is on the loose after holding up a local Family Dollar store.


text:
Why buy this book?
- "an oustanding debut novel for teenagers" The Guardian
- "Syson brings history alive" The Observer
- "a fantastic historical fiction debut" The Bookseller
- "a compelling story of politics and passion, bravery and love" Booktrust
- "Highly recommended" Morning Star
- Also available as an interactive Multi-touch iBook from Apple's iBookstore
ISBN listings
A World Between Us
"An epic romance set against the backdrop of the Spanish Civil War"
About the book
Spain, 1936. Felix, a spirited young nurse, has travelled to Spain to help the cause of the Republicans in the Spanish Civil War. But she is also following Nat, a passionate young man who has joined the International Brigades fighting Franco. And George - familiar George from home - is not far behind, in pursuit of Felix ...
As Spain fights for its freedom against tyranny, Felix battles a conflict of the heart. With the civil war raging around her, Felix must make choices that will change her life forever. An epic and moving historical adventure from debut author Lydia Syson.
More about this Book
A WORLD BETWEEN US is also available as an interactive ebook on the iBookstore, featuring original letters from nurses during the war, timelines, interviews with experts as well as the last surviving member of the International Brigades. Click here to go to the iBookstore and watch a preview below:
'I feel guilty, safe here.'
'Not exactly safe.' A louder explosion, not so far away that they couldn't feel it shake the pavement. He pulled her even nearer. She felt as light as air.
'Maybe.' She shrugged. Everyone had picked up something of Madrid's fatalism. He stopped and she knew he was looking at her, curiously, trying to decipher her shadowed face.
'You like the danger, don't you?' he teased her, gently. 'Admit it.' Nat turned and took her face in his hand, stroking her cheek with his thumb, studying her as closely as the darkness allowed.
'No, no, of course I don't.' Felix was almost too embarrassed to enjoy the sensation, this warm weightlessness, as if every cell in her body were gently expanding. 'Not really.' She tried to look away, but he wouldn't let her. He'd seen through her.
'A bit of you . . . ?'
'Well, it's exciting,' she admitted, meeting his eyes again, at last. 'You know it is.'
'Life and death.'
That was it. He knew. 'It makes you feel so alive . . .'
' . . . A part of things . . . ?'
' . . . Here and now.'
Letter from the editor
This is YA historical fiction at its best.
Sarah Odedina, Managing Director
Editions available
Shipping Details
UK shipping
£1.00 for a single book
FREE for two or more books
International shipping
£5.00 for the first book
+ £2.00 for each additional book
Having trouble adding to cart? Make sure you've accepted cookies at the top of the screen.


text:
Entries tagged with: Bowery Presents
initial schedule of Bowery Presents shows at Woodstock's Bearsville Theatre (Mac DeMarco, Mikal Cronin, JSBX, more)
Last month it was announced that NYC-based concert promoters Bowery Presents would begin booking shows at Bearsville Theater in Woodstock, NY. Since that announcement, we've mentioned a few upcoming Bowery shows at the venue, including Mac DeMarco, Hiss Golden Messenger, and Blake Mills. The rest of Bowery's initial schedule there includes Jon Spencer Blues Explosion, Strand of Oaks, Heartless Bastards, Mikal Cronin and more.
Tickets for all shows on the initial Bowery-booked Bearsville schedule go on sale Friday (5/15) at noon, and a few have AmEx presales starting today (5/13) at noon. Check out the full schedule below.
Continue reading "initial schedule of Bowery Presents shows at Woodstock's Bearsville Theatre (Mac DeMarco, Mikal Cronin, JSBX, more)"
NYC-based concert promoters Bowery Presents have expanded their reach with the addition of Woodstock's Bearsville Theater to their roster. The press release reads:
This exclusive collaboration will continue a long tradition of bringing new and established nationally touring artists to the Theater. "My partner Jim Glancy and I have talked over the years about opening a venue upstate someday; after meeting Nicolas and hearing his vision for Woodstock Commune and how the Theater fits into this, we felt the stars had aligned. We are very excited to carry on what Albert Grossman started in the '60's with Dylan, The Band, Janis Joplin and so many others who made pilgrimages to Woodstock." said John Moore, partner at Bowery Presents.No Bowery-booked shows have been announced yet, though the venue is open and operating with self-booked shows.
The Theater and Bowery will be presenting year-round entertainment, including local, national and international talent, working together to restore the Theater to its historic place in the music scene. "We are so excited to partner with Bowery Presents, which plays such an important role in the independent music scene." says partner/Operator Nicolas Geeraerts. "The collaboration is part of a larger revitalization of the property, which not only includes the Theater, but also the historic Bear Café and hip newcomer Commune Saloon with its large bluestone patio."
Jeff Mangum played there in 2011. Andrew Bird played there even more recently. Video of that can be watched below.
In addition to NYC and Woodstock, Bowery Presents books venues in Philly, Boston, Long Island, Maine, other areas of NY, New Orleans, Atlanta, and ALABAMA.
Continue reading "Bowery Presents booking Bearsville Theater in Woodstock"
current Google street view...
LA's new Teragram Ballroom is set to open this spring with shows by Delta Spirit, Palma Violets, Jaga Jazzist, Nick Waterhouse and more already on the schedule. The long-rumored new "Bowery Presents Los Angeles" venue is in fact associated with NYC-based Bowery Presents, but not completely:
New York City music impresario Michael Swier and the Bowery Ballroom / Mercury Lounge team (Michael Winsch / Brian Swier) have joined forces with LA business owner, Joe Baxley (Broadway Bar), to launch the Teragram Ballroom, a mid-sized live music venue located on the fringes of burgeoning downtown Los Angeles.The capacity is about 600, just like Bowery Ballroom and Music Hall of Williamsburg in NY. And a press release reads:
The old-Hollywood era theater housing the Teragram Ballroom has been through major renovation to deliver what Swier's iconic venues have always offered: an exceptional listening experience, unimpeded sight lines, and an intimate environment that caters to both musical artists and those coming to take in the performances.Tickets are on sale for the first-announced shows, which are listed below...
"It's exciting to see the Teragram Ballroom come to life on this western edge of downtown Los Angeles," says Michael Swier, who lived in LA from 1974 to 1978 and feels a certain comfort and familiarity in the city of his youth. "You can feel the pulses of a reawakening in the neighborhood, I feel privileged to be part of this new vitality."
Located at 1234 West 7th Street, the 9,000 square-foot theater offers special features for artists and audiences: three dressing rooms, dedicated loading dock, spacious backstage, state-of-the-art sound system, three bars and a restaurant with comfortable circulation throughout.
"As with our New York venues, we have built the Teragram Ballroom for the bands as much as for the audience," added Michael Swier. "The breadth of our experience has culminated in this incredible project." The venue's name reflects the influence of a crucial contributor who passed away before reaching this point on the long journey: "Teragram" spelled backwards honors Michael Swier's late wife, Margaret Hannigan, who helped found the early venues.
Continue reading "Teragram Ballroom is a new LA music venue from Bowery Ballroom & Mercury Lounge founder"
It took us a minute to fully realize it, but since losing Webster Hall, Bowery Presents has been booking shows at the similarly sized Manhattan venue Stage 48. You may already realize this. You may not care. Regardless, it's happening. Is it temporary? We don't know. Have you been to the venue? What do you think?
Not all Stage 48 shows are Bowery Presents. Kaiju Big Battel and Bomba Estereo are not.
The Horrors, Sleep, and Justin Townes Earle are all Bowery Presents shows though (as are Sir Sly, Wolf Gang, Secret Someones, J. Roddy Walston & The Business, Fly Golden Eagle, EOTO, and Watsky).
We actually have a pair of tickets to give away for the 9/9 Justin Townes Earle show. Want them? Details on how to enter to win below...
Continue reading "Bowery Presents books shows at Stage 48 now; Win tickets to Justin Townes Earle"
2013 must have been a big success because Jim James and company are doing it again:
Today, Cloud 9 Adventures and The Bowery Presents proudly announce the second edition of My Morning Jacket's One Big Holiday - the band's ultimate fan experience and destination concert event. My Morning Jacket brings their epic live performance, and 2500 lucky fans as witnesses, back to the fully renovated Hard Rock Hotel Riviera Maya from January 31-February 4, 2015 for a 4 night all-inclusive concert adventure of a lifetime.Tickets and more info at the event's site.
"We are so excited for this second year of One Big Holiday...the second of what we hope will be many more to come! The first one was so beautiful we just knew we had to do it again...what could be more fun than spending quality time with a bunch of sweet folks- old friends and new- in a beautiful place celebrating music/art/peace and love!!! Let's get together and celebrate!" - My Morning Jacket
After bringing the heat last year in the stellar concert courtyard within the resort, One Big Holiday will once again feature three full shows under the stars by My Morning Jacket. Once again returning to join the band on this adventure will be Preservation Hall Jazz Band, as well as newcomers War On Drugs, Dr. Dog, Dawes and Sylvan Esso who will each perform one show, plus special guest DJ Biz Markie. Fans are also in for a special treat as Band of Horses will perform two full shows, including one acoustic performance as the sun goes down.
MMJ have no other upcoming dates at the moment, but Sylvan Esso do.
Bowery Presents' new 2000-capacity Brooklyn Classic update: applying for liquor license, planning to open this year
Earlier this year, it was revealed that Bowery Presents were hoping to open a new 2000-capacity venue in East Williamsburg that would be called Brooklyn Classic (in the factory building at 319 Frost St). A new article for The Brooklyn Paper has more details. Regarding the venue layout, the article says:
The venue will have a similar layout as the Music Hall of Williamsburg, with a large open theater ringed by a balcony and smaller bars, as well as an enclosed outdoor courtyard for smokers.Bowery Presents also appeared before the neighborhood's Community Board 1 this week to get approval for a liquor license:
Some neighbors at the meeting of the panel said they are concerned that the venue will inundate their streets with cars and drunken music lovers.The Brooklyn Paper also mentions that Bowery Presents plans to have Brooklyn Classic open this year. That should fill the void of Bowery Presents no longer booking at Webster Hall.
"It is hard enough to park around here as it is," said Jonathan Ellis. "Another 2,000 people here is a lot."
The board's votes are strictly advisory, so even if it disapproves of the booze permit, it is still up to the state liquor authority to make the final approval.
Webster Hall taking over all their own concert booking, with help from Ric Leichtung (Bowery out in September)
Webster Hall marquee, June 2012 (more by Dominick Mastrangelo)
Webster Hall's 1400 capacity Grand Ballroom has long been a place that Bowery Presents books concerts. It's there they can put artists that are theoretically too big for Bowery Ballroom and too small for Terminal 5.
A powerful force in the music industry, Bowery Presents can hold on to a band's NYC concert history for the length of its career by placing the band in rooms of various sizes. They have options: tiny Mercury Lounge to the new Rough Trade to the giant Terminal 5 to the even bigger Barclays Center, not to mention Central Park Summerstage and Celebrate Brooklyn at the Prospect Park Bandshell, Radio City, Beacon Theater, Town Hall, and possibly a new space in Bushwick that will be Webster Hall's successor, and even MSG. But now they'll have one less.
As of September 1 (not counting shows which are already booked), Webster Hall's recently-enlarged team of five talent buyers will be doing it all themselves. They already booked the smaller rooms, but now that team will collectively book all of Webster Hall's rooms which include the Grand Ballroom, The Studio, Marlin Room, and the new Slake (formerly The Wall).
Webster Hall now counts Ric Leichtung of 285 Kent fame as one of their own. The rest of the booking team is Heath Miller, Kenny Schachter, Alex Rossiter and Laura Bo Sherman.
Is Webster Hall crazy thinking they can compete with their 1400 person room on their own? Time will tell, though maybe it doesn't matter that much since Webster Hall's regular club nights seem to do just fine for them.
An email Webster Hall sent out to booking agents reads:
We will now be better suited to maximize the artist experience and fan enjoyment by focusing on every detail for each show that Webster Hall hosts, which already includes The Studio at Webster Hall, Marlin Room at Webster Hall, and our new venue Slake (around the corner from Penn Station).Good luck Webster!
After 130 years, Webster Hall retains its local focus and has strategic alliances in place to ensure that New York City is an artist's most important experience. We welcome you to pay us a visit or to let us know when we can visit you.
Upcoming Bowery Presents-booked shows at Webster Hall include Warpaint, Gary Numan, Sam Smith, Real Estate, Dillinger Escape Plan, Mac DeMarco, Black Lips, Tycho, Future Islands, Wye Oak, Tokyo Police Club, Elbow, The Menzingers, Old 97's, The Notwist, First Aid Kit, Kaiser Chiefs, Jagwar Ma, Tune-Yards, and more.
The Daily News seems to think so:
One of the partners behind the Bowery Ballroom, Terminal 5 and a string of popular music venues plans to open a massive 2,000-capacity venue in Brooklyn's hipster haven.If this happens, that would give Bowery Presents Mercury Lounge---> Bowery Ballroom--->Webster Hall (sort of)--->Terminal 5 in Manhattan, and Rough Trade-->Music Hall of Williamsburg--->Brooklyn Classic in North Brooklyn.
The gigantic live music space would open as Brooklyn Classic, taking over a red brick factory building currently home to a steel fabricator at 319 Frost St., according a liquor license application to the local community board.
The application from Frobo LLC ties back to Jim Glancy, a veteran of promotional giant Live Nation and partner in The Bowery Presents, a powerhouse in the indie music scene.
(thanks Hiro for the link!)
While the venue is new, the building itself has a rich history, beginning in 1927, when it opened as the Westbury Movie Theatre. It remained a popular facility until the 1970s, until attendance decreased dramatically. "It really became very, very delapitated, and ultimately closed down," said Michael.Bowery Presents, who already handle the booking for NYC shows at Mercury Lounge, Bowery Ballroom, Music Hall of Williamsburg, Terminal 5, and a few other venues on certain occasions (not to mention expanding to Philly, New Orleans, Boston, and South), has now taken on a new Long Island location: The Space at Westbury. Not to be confused with Hamden, CT's The Space, The Space at Westbury is a 1,500-capacity venue located on 250 Post Avenue in Nassau County's Westbury, NY, and it officially opens with its first show tonight (10/4).
The building's current owner, Cyrus Hakakian, was planning to tear down the building and turn it into retail. But when examining the building's interior, Michael said Hakakian had a change of heart. "He was so impressed with the majesty of this building," Michael said. [LI Herald]
Tonight's show is a stop on the Fountains of Wayne, Soul Asylum, Evan Dando tour (which also hits Webster Hall on Saturday). Tickets for tonight's show are available.
Other upcoming shows include Stephen Lynch on 10/11 (tix), Justin Townes Earle on 10/25 (on sale today at noon), Dr. John on 10/26 (tix), Matisyahu on 12/10 (tix), and more.
Check out the full list of upcoming shows here. Tickets to all Space at Westbury shows are available via Ticketmaster.
Though we don't have many details, we are sad to report that the music industry is today mourning the loss of Adam Fisher, a sound engineer and tour manager who has worked for Bowery Presents, Knitting Factory, The Polyphonic Spree, Crocodiles, and many more. Those who knew him, loved him, like the Dum Dum Girls who already Instagrammed the above picture with the caption "love you adam", and tweeted, "Very grateful for the time we spent touring the world with Adam Fisher. Please take care of yourselves everyone. <3". Young Prisms and NOTHING have also acknowledged the great loss. Rest in Peace Adam.
* read a tribute to Adam by Mishka Shubaly
* Yeasayer tweeted, "RIP Adam Fisher Yeasayer Tour Manager 2010. So many crazy memories. "
* Memorial being planned at the Well
After opening Union Transfer in 2011, Bowery Presents will be opening (or re-opening, rather) a second Philly venue this year, the 150-capacity Boot & Saddle on Broad Street, which closed in 1995. A press release reads:
While live music will pack the back hall of the new Boot and Saddle beginning at 8pm some 150 nights of the year, a separate 60-seat main room and kitchen will be open seven days a week, from 5pm 'til 2 am, featuring a full-service bar, 10 rotating local craft beers, seasonal beers from around the United States, as well as inexpensive domestic crowd favorites.The venue opens on September 9 with Ted Leo and Aimee Mann's new band, The Both playing. Full initial schedule below...
With all these innovations and improvements, some elements of the old Boot and Saddle will still inform its new look. Preserving the venue's original tin-ceiling and walls and hardwood floors, the new proprietors are pleased to maintain a welcoming, time-capsule décor--complete with folk-art cowboy murals--reflecting the building's history as Philadelphia's one-time only country bar. And, yes, the iconic neon sign stays, of course.
Boot and saddle is a partnership between Sean Agnew's R5 productions, New York City's The Bowery Presents and FCM's Mark Fichera and Avram Hornik
Continue reading "Bowery Presents re-opening Philly's Boot & Saddle"
NYC concert propmoters Bowery Presents, though no longer at the old Wellmont Theater in NJ, have been expanding and moving South. This week they've officially confirmed the rumor that they're re-opening a historic theater in New Orleans called the Civic Theatre. The initial lineup already includes Passion Pit, The Black Crowes, BRMC, John Waters and more. Check out the full press release and initial schedule below...
Continue reading "Bowery Presents booking New Orleans' Civic Theatre"
Wellmont Theatre in 2012 (more by Dana (distortion) Yavin)
We recently got the upsetting news that Hoboken, NJ venue Maxwell's is closing (check out the venue's final shows) and the more positive news that another NJ venue, Starland Ballroom is re-opening after damages from Hurricane Sandy.
Now there's even more going on in the NJ venue world. It's just been announced that after MGMT's sold-out Wellmont Theatre show, Bowery Presents will no longer be booking the Montclair venue. According to an article on Baristanet and confirmed by us, Live Nation (who book NYC shows at Irving Plaza, Gramercy Theatre, and more) will now be booking the venue:
Led by Live Nations Club and Theatre Team overseen by Sean Striegel and Jason Stone, Live Nation will be actively looking to present artists. Booked by the New York Team of Sean Striegel, Jason Stone, Jay Belin and Christian McKnight, Live Nation plans to continue to expand on the programming of the venue.David Byrne & St. Vincent just played one of the last Bowery-booked shows at the venue this past Wednesday (6/12). Check out pictures of that show.
NYC-based concert promoter Bowery Presents, who have expanded over the years to NJ, Boston, Philadelphia and across the Northeast, are getting bigger again. This press release recently went out:
Tim Sweetwood has been hired by The Bowery Presents to promote concerts in his home city, Atlanta, as well as other available opportunities throughout that region as part of the newly launched The Bowery Presents: South. Sweetwood has been the talent buyer at the Masquerade and has produced shows in and around Atlanta for the past seven years. Tim has worked with artists to grow them beyond the Masquerade, culminating in the recently completed Shaky Knees Festival. The launch of The Bowery Presents: South continues the independent promoter's commitment to embracing regional and local music industry professionals, when they expand into new markets.As mentioned above, Bowery Presents: South will start out with Tim in Atlanta with plans to promote shows "throughout that region". That would include Athens, Georgia, Birmingham, Alabama, and rumor is that Bowery will be doing shows at an old theater in New Orleans (The Civic Theater). Stay tuned for more details, and watch out Live Nation!
"I am thrilled to say that I am now part of The Bowery Presents," says Tim. "I think this marriage comes at the perfect time. My business and relationships have been rapidly expanding, and I believe being part of The Bowery Presents will help move everything to the next level. Regional expansion has been a goal of mine, and I am looking forward to the new relationships that will come from this move.
Look for more details soon, with shows beginning this fall.
Grimes @ Music Hall of Williamsburg (more by Amanda Hatfield)
Josh Moore, talent buyer at Bowery Presents, is in charge of booking shows at Music Hall of Williamsburg, but you'll also find gigs he booked at places like Brooklyn Bowl, Webster Hall and Terminal 5. You can also blame him for both Jam Cruise and Holy Ship. Like his his associate Johnny Beach and ex-Bell House/Union Hall/Rock Shop booker Jack "Skippy" McFadden before him, Josh gave us a list of his favorite albums of 2012. Check it out, along with some related videos, below...
Continue reading "Josh Moore from Bowery Presents: Best Albums of 2012"
Bowery Ballroom (more by Tracy Allison)
If a show is happening at NYC's famous Bowery Ballroom, it was booked by Bowery Presents talent buyer Johnny Beach (who started at the company booking Mercury Lounge). Johnny also keeps busy by co-booking Webster Hall, Terminal 5, Union Transfer in Philly, and other Bowery Presents-affiliated venues. The man books shows all day and is literally at one or more almost every single night. He told us what albums he listened to the most in 2012. Check out his list, and some related videos, below...
Continue reading "Johnny Beach from Bowery Presents: Top 10 Albums of 2012"
Bowery Presents expands more in Boston, hires TT the Bear's & Great Scott promoters, opening new venue The Sinclair
The Bowery Presents, an independent promotion company based in New York City, and consulting Chef Michael Schlow are opening The Sinclair, a live-music venue and restaurant launching this fall. The livemusic space will accommodate 525 people with plans to host 200 shows annually, while the restaurant will seat 104 and will be open seven days a week. Located at 52 Church Street in the heart of Harvard Square [in Boston, MA], The Sinclair is the first restaurant project for The Bowery Presents...This press release comes after last week's announcement that Bowery Presents had hired Carl Lavin and Josh Smith who will "continue handle the talent buying and promotion of concerts at Boston's Great Scott and TT the Bear's Place. Additionally, Lavin and Smith will work in conjunction with Josh Bhatti for talent buying and promotion at Royale and the forthcoming Sinclair." Up until all of this, Royale, which opened in 2010, was the only venue in Boston Bowery Presents was booking exclusively. Now Bowery books all four of these venues exclusively, though the Sinclair is the only one they own.
"We are excited to open The Sinclair in such a historic, dynamic neighborhood," said Jim Glancy of The Bowery Presents. "The Bowery Presents has evolved over the years - from promoting concerts in small, intimate venues to arenas, amphitheaters and beyond. To build a venue in Boston, typically we would have retrofitted something in an existing space. For this project, we are taking the lessons that we've learned from our previous endeavors and creating The Sinclair with the best experience in mind for concert patrons and artists. We can't wait to share it with the citizens of Cambridge and the Boston area."
So far The Sinclair has shows set with Andrew Jackson Jihad (tour dates), Roky Erickson, Converge/Torche (tour dates), Title Fight (tour dates), David Wax Museum, Patrick Watson (tour dates) and others. Visit the Sinclair's website for the full upcoming schedule.
going HARD in NYC (more by Zachary Alex Stern)
NY Times reports:
Big money is flowing into electronic dance music. In the latest example of corporate interest in this once-ignored market, Live Nation Entertainment on Tuesday acquired Hard Events, a Los Angeles company that has put on popular festivals and concerts across North America.Deadmau5 also recently posted a note on his Tumblr saying "we all hit play", and maybe his fear of sinking cruise ships is why he is not on the lineup of this year's Holy Ship, which by the way is a highly successful venture (that sold out before the lineup was even announced) co-promoted by Bowery Presents AND HARD EVENTS (and that's just one of many events Bowery Presents does with Hard who are now owned by Bowery's biggest NYC competitor Live Nation).
Yet such investments are fueling fears that a bubble is taking hold in the world of electronic dance music, or E.D.M., jeopardizing the creative and commercial health of the music. The issue has been intensely debated inside the music business, and recently some of the genre's stars have sounded alarms as well.
"E.D.M. has turned into a massively marketed cruise ship, and it's sinking fast," the D.J. and producer Deadmau5 wrote on his Tumblr page on Tuesday. "All I'm trying to do is put on my life jacket and swim as far away from this shipwreck as fast as I can."
Rough Trade Retail Group (RTRG) proudly announces the forthcoming opening of Rough Trade NYC, Williamsburg, New York, USA.Stay tuned.
Due to open in Autumn this year, Rough Trade NYC will offer a large saturnalia for music lovers of all ages (even larger than multi-award winning Rough Trade East, London, UK).
In addition to being a place to discover, browse, debate and purchase the finest recorded music, Rough Trade NYC will partner with The Bowery Presents to feature a live performance area for in-store gigs, as well as operating at night as an intimate live music venue. The Bowery Presents has a strong history of operating first class concert venues including the Music Hall of Williamsburg located in the same neighborhood as Rough Trade NYC.
Rough Trade NYC will pay particular attention to its transatlantic dynamic by linking-up with Rough Trade's London stores, encouraging customers (and artists) in each country to interact across the ocean.
"At long last, we can finally confirm the next bold step in our evolution" says Rough Trade's co-owner, Stephen Godfroy. "We're extremely excited at the prospect of handing over the 'blank canvas', that is a Rough Trade store, to the music lovers of New York, allowing them make it their own culture agora, just as the people of London have so successfully achieved, with downturn-defying results."
"The Bowery Presents has always maintained a commitment to developing artists at the inception of their career, with Rough Trade NYC we have that opportunity in an exciting neighborhood and we are excited about the retail store and venue combination concept" says John Moore, partner, The Bowery Presents.
Rough Trade NYC also heralds the forthcoming arrival of a US version of the new, soon to launch, roughtrade.com online store, which will offer MP3 downloads alongside CD and vinyl, complete with subscription services.
Further exciting details will be announced in the months to come.
Hammerstein Ballroom upgraded & can now be booked by anyone (Odd Future played there, Tenacious D on sale)
photos by Julie Schabel
Odd Future @ Hammerstein Ballroom - 3/20/2012
As you may have noticed when Bowery Presents announced an Odd Future show at Hammerstein Ballroom, the big NYC venue is no longer exclusive to Live Nation. The room also received a technology uprade. Venues today reports...
One of New York's iconic theaters is being retooled into a HD broadcast-capable concert facility, equipped to stream or broadcast any event live in beautiful 1080p.Tickets are on sale now for AEG-presented Tenacious D show at Hammerstein Ballroom which we're also giving away a pair of tickets to.
The iconic Hammerstein Ballroom, built in 1906 and once a popular stop for vaudeville acts, is now home to a new revolution in performing arts -- the complete integration of a state-of-the-art broadcast and recording studio. Since 1997, the Hammerstein has been the anchor of the Manhattan Center, a television and music studio used to record musical performances for television, special concert events and other programming.
In December, the Manhattan Center made two large changes to open the space up to new clients. First, they ended Live Nation's exclusive booking contract for the facility, opening up the 3,500-capacity standing room concert hall to independent promoters and anyone interested in booking the building.
The Manhattan Center management team also completed the installation of TV1, a new fully HD recording studio that allows any content performed at the space to be streamed in HD, or digitally delivered for future distribution. The upgrades come on top of some physical improvements to the building including renovated dressing rooms and a new marquee.
A few more pictures from the Bowery-presented Odd Future show, below...
Continue reading "Hammerstein Ballroom upgraded & can now be booked by anyone (Odd Future played there, Tenacious D on sale)"
The Capitol Theatre in Port Chester to host live shows again (thanks to Pete Shapiro) (and Bowery Presents)
The Capitol Theatre (note the new URL), located in Port Chester, NY, was built in 1926 and has been the home for a number rock concerts over the years, including shows by Pink Floyd, Janis Joplin, The Grateful Dead, and others. By the 1980s, the theatre began to book less and less concerts and more recently it has been used for events like weddings and bar mitzvahs. It was added to the National Register of Historic Places in 1984.
Ex-Wetlands owner/current Brooklyn Bowl owner Peter Shapiro, in partnership with Bowery Presents, plans to begin booking shows there again, with a re-opening planned for mid-2012. According to a press release,
"The Capitol Theatre is a rock and roll icon and we are going to treat her as such," says Shapiro. "We are going to spoil her and give her the best of everything - the best sound, the best lights, and the best video projection technology of any theatre anywhere. Our plan is to turn the knob to 11 in every way possible."John Moore of Bowery events also had this to say:
"Since spending Thanksgiving weekend 1992 at the theatre with Phish, I've dreamed of promoting at The Cap' one day," says John Moore, partner at The Bowery Presents. "We are excited to partner with Peter on the reopening and introduce a new generation of talented performers to its legendary stage, as well as reacquaint some of the biggest names in music with the house. We look forward to creating memorable concert experiences and reestablishing Port Chester as a destination for music lovers."The Capitol has a 1,835-capacity, 65-foot ceiling, a general admission floor, seated balcony, VIP seats, and six presidential box suites. Its Port Chester location is 22 miles from NYC and is accessible by I-95 or by taking the train from Grand Central to the Port Chester Metro North station.
The NY Times points out that there may be some competition from other local theaters:
The 500-seat Ridgefield Playhouse in Connecticut, which is about 30 miles from Port Chester and puts on about 100 concerts a year, insists that musicians not play within 60 miles for two months before a concert and one month after. The Paramount Center for the Arts, a 960-seat theater in Peekskill, N.Y., also about 30 miles from the Capitol, in recent years has presented shows with Gregg Allman, Bob Weir of the Grateful Dead, and the B-52s. It has even stricter stipulations: bands must not play within a 90-mile radius for two months before and three months after a concert.But Shapiro has said that he "would not make similar demands of acts, partly because he does not consider it necessary. The Capitol, he argued, is much larger than those other stages, so he can court a different caliber of band."
The Paramount's demographic also differs from most Bowery Presents shows. Hopefully The Capitol will start bringing more interesting shows to Westchester, like fellow (but smaller) Westchester venue Tarrytown Music Hall has done with shows like Jeff Tweedy, Andrew Bird, Sharon Jones & the Dap Kings, and The Zombies (not that Tarrytown isn't also bringing in plenty of shows for baby boomers). We'll probably see a lot of similarities between The Capitol and NJ's similarly-sized and Bowery-booked Wellmont Theater which is also about the same distance from NYC in another direction. The Wellmont gets everyone from Chicago to Passion Pit to Dark Star Orchestra.
A picture of The Capitol's interior, Peter Shapiro at the Okayplayer holiday party, some old fliers and the full press release, below...
Continue reading "The Capitol Theatre in Port Chester to host live shows again (thanks to Pete Shapiro) (and Bowery Presents)"
Pitchfork reports:
Pitchfork, The Bowery Presents, and Killscreen are postponing FORMS, the NYC-based event series we collectively created as a way to celebrate the best of music, art, games, and the intersections in between. As the series took shape these past few months, we found it growing bigger and more complex in very exciting ways. We followed those threads, expanded the vision, and simply ran out of time. Pitchfork, Bowery Presents, and Killscreen have a history of throwing spectacular events and producing great content, and we have decided to give ourselves more time to ensure that FORMS is the best it can be. For now, we plan to take a brief pause and provide more information later.FORMS was supposed to go down in multiple NYC venues this February.
Pitchfork Fest (more by Dominick Mastrangelo)
The online music magazine that runs the Pitchfork Music Festival in Chicago -- the influential outdoor showcase for indie bands -- has plans to start a new festival in New York City next February, teaming up with the one of city's largest music promoters, The Bowery Presents.
The new festival in New York will be called "Pitchfork Presents: Forms" and will include works by visual artists and game designers at galleries, museums and unconventional performance spaces around the city, along with four days of performances at clubs run by Bowery Presents, organizers said.
Christopher Kaskie, the president of Pitchfork, said his company had been seeking a way to do a festival in New York for several years, but did not think a large, outdoor event at a park, like the Chicago festival, would be successful in a city with such a crowded social calendar and so little public space.
"We never thought that kind of a model would really work that well in New York," he said. "We've been strategizing for a number of years on how we could come up and do a festival that was impactful and unique."
The decision was reached earlier this year to do most of the events inside at established clubs and to incorporate more visual artists and independent video-game designers into the mix, creating some multimedia events. "It's going to be more of an urban festival," he said.
John Moore, a partner in The Bowery Presents, said the lineup of bands for the concert had not been determined, but he expects to book between 50 and 75 acts, all in the indie vein. Passes to the entire festival will be available, but people may also buy a ticket to a single night of performances one of the promoter's clubs - The Music Hall of Williamsburg, the Bowery Ballroom, the Mercury Lounge and Terminal 5. The prices for tickets have yet to be announced. Those tickets will be in the $15 to $30 range. Some of the multimedia events at galleries, museums and unconventional spaces during the day will be free, he said. [NY Times]
words & photos by Colin Kerrigan
Rumors that Sean Agnew of R5 Productions was planning to open his own venue had been swirling around for a couple years now but were always denied by Mr. Agnew. However, everyone had a sense that it was bound to happen eventually. Earlier this year it was finally confirmed. Agnew/R5 Productions teamed up with NY promoters Bowery Presents and Avram Hornik and Mark Fichera of Four Corners Management to open a new Philly venue.
Union Transfer, which was most recently a gigantic Spaghetti Warehouse and was apparently at one time a train depot back in the day, had captured the attention of all the music lovers in the city prior to its opening. Everyone wanted to know what it was like and what the sound was like (R5 boasted that it would be the best sounding venue in the city). On Wednesday night they found out.
The space has very tall ceilings with chandeliers hanging down, both standing and seated balconies (with great sightlines), three different bars each with their own unique atmostphere, plenty of floor space and the sound lived up to expectations.
Even though the venue has had only one show so far but it's safe to say that the venue is one of, if not the best, venue in the city.
Clap Your Hands Say Yeah and Polica played that first show at the the venue (one night after they played Bowery Ballroom in NYC). Here are some pictures from the show. They continue below...
Continue reading "CYHSY & Polica played the 1st show @ Philly's new Union Transfer (pics)"
a musician playing Mercury Lounge (more by Chris La Putt)
"The owners of famed New York City nightspot Mercury Lounge on Monday hit concert promotion giant Live Nation Entertainment Inc. and the club's former chief booking agent with unfair competition and contract claims, claiming Live Nation poached the agent." [Law 360]Messy.


text:
Bourjois rose d'or
123 reviews
73% would repurchase
Package Quality: 3.7
Price: $$
Package Quality: 3.7
Price: $$
INGREDIENTSTALC, MICA, CI 77891 (TITANIUM DIOXIDE), SYNTHETIC FLUORPHLOGOPITE, CI 77491 (IRON OXIDES), PARFUM (FRAGRANCE), BENTONITE, CI 77492 (IRON OXIDES), PARAFFINUM LIQUIDUM (MINERAL OIL), ZEA MAYS (CORN) STARCH, CI 77499 (IRON OXIDES), CI 77163 (BISMUTH OXYCHLORIDE), CI 15850 (RED 7 LAKE), CI 77007 (ULTRAMARINES), MAGNESIUM ALUMINUM SILICATE, SILICA, CI 15850 (RED 6 LAKE), LANOLIN ALCOHOL, CI 75470 (CARMINE), CI 19140 (YELLOW 5 LAKE), SODIUM METHYLPARABEN, AMMONIUM SILVER ZINC ALUMINUM SILICATE, METHYLPARABEN, PROPYLPARABEN, DEXTRIN, TETRASODIUM EDTA, BHT, PROPYLENE GLYCOL, ASCORBYL PALMITATE, GLYCERYL STEARATE, CITRIC ACID Updated as of November 14, 2011
Age: 18 & Under
Skin: Very Dry, Fair, Warm
Hair: Blond, Straight, Fine
Eyes: Blue
Whoa. I just bought this on midseasonsales and I'm wowed. I had been looking for a new blush for ages and after reading the good reviews I decided to try it. I was a bit worried when I saw what it looked like in the package because it looked extremely shimmery! But when I applied it it just gave me a nice glow without looking fake. It looks very natural and one sweep does the trick for me. I'm very pale with blonde hair and blue eyes and this is perfect for me. It is buildable but with me that looks a bit weird so I'll stick with one sweep. The package is a bit tricky at first but once you get the hang of it it's allright, just dont use too much force. On the whole a lovely blush, will definetly repurchase and try other colors of this.
Age: 19-24
Skin: Combination, Fair, Not Sure
Hair: Brunette, Other, Other
Eyes: Brown
This blush is one of the cutest cheap things you can buy out there. My obsession with Bourjois blushes started around 6 years ago. I own and adore many HE blushes (Chanel, Lancome, Nars etc...) but Bourjois is my cheap fix (costs approximately 10 euro in Greece). I love the cute, small, round pots and I love that the packaging matches the color of the blush so I can reach immediately for the one I want. The smell is not bothering me at all, on the contrary, it gives it a retro feeling that I like a lot, plus it disappears when I put it on. The fact that they are baked means that they can go hard on the surface but it hasn't been a real problem for me all these years. Now the particular shade: Rose D'Or is a medium pink with gold shimmer. It looks a bit scary in the pan but once it's applied the shimmer is really subtle (almost undetectable) and the color is a girly, bubblegum shade. On my skin it always apply very nice, sheerly and evenly, in fact I like it way more than some expensive and really pigmented blushes I own. Pale people (like myself) should be careful though, you should use a light hand with this one. In my honest opinion it looks better on neutral/cool skintones but I have seen it on a warm-toned girl and it looked nice on her too. If you don't like Rose D'Or the whole line of Bourjois blushes is worth checking out. I also adore Lune D'Or (a staple if you're fair) and Rose De Jaspe.
Age: 25-29
Skin: Oily, Fair-Medium, Not Sure
Hair: Blond, Wavy, Fine
Eyes: Hazel
I bought this very recently and was very excited about it, but I made the unforgivable mistake of using the brush that comes with it to try it for the first time: suddenly I wasn't seeing cheeks anymore, I was seeing easter eggs:-D That scared me a bit but I didn't lose faith, I just used my normal soft blush brush the next time: instant, sexy glow:-)).
Now in the container this is bubblegum pink with golden streaks; pretty to look at, but a bit scary. On my face it turns into a very slightly shimmery, rosy color. I use it with the lightest hand possible, a little bit goes a long way ladies, so the fact that it's baked powder and therefore not too easy to get onto the brush is very convenient to me; otherwise I'm afraid I would overapply all the time.
The scent is noticeable as you open the container and I find it divine; reminds me of vanilla with a slight hint of cinammon. I can understand many of you wouldn't want your blush to smell, but I personally adore it, makes using it even more fun.
Now about the package, I am one of the people that find most Bourjois containers cute, not cheap, but it's a fact that this looks a little brittle. I'm not crazy about the brush lying on top of the actual product and not somewhere next to it (but that would require totally transforming the container) but I think I'll be tossing it anyway as it doesn't do the trick for me.
The price is fine, and considering this will probably last for ages, more than reasonable.
All in all I love this and I hear it also comes in other tempting colors - I'll be getting the lune d'or version sometime soon. Highly recommended.
Age: 36-43
Skin: Combination, Fair-Medium, Cool
Hair: Blond, Other, Other
Eyes: Blue
I ADORE this blush!!! It's a sassy bubblegum pink with just a hint of gold and slight shimmer. I agree with one of the other reviewers that said this is better for touch ups rather than initial application, but it's also pretty enough to just swipe on easily for a natural flush when I'm in a hurry and need to get out the door. Its dainty compact with a mirror is perfect for my purse m/u bag. I read somewhere that this is one of the oldest and most classic blushes and it does have a vintage, classic look to it. I also love the light, clean scent, fresh but not overpowering. I am a m/u brush snob but have to admit that I really like the small little round brush that comes with this! I just swirl it in a circular motion on the apple of my cheeks and it looks so pretty and natural. I love this blush so much that I bought two of them! I would recommend this to anyone who can wear pink blushes and if not this color, then try one of the other shades. This just happens to be the shade that looks best on me and it's a good thing because I would buy them all! LOVE this!!!!
Age: 30-35
Skin: Oily, Fair, Not Sure
Hair: Brown, Other, Other
Eyes: Blue
Lovely colour. Stays on all day. I still look fresh and alive at the end of the day. The brush is a little scratchy though. Will have to get around to buying a proper brush.
Age: 36-43
Skin: Sensitive, Fair, Cool
Hair: Brunette, Wavy, Medium
Eyes: Green
i love this colour and i love the scent. the scent is feminine and subtle, and not little girly, and it doesn't last long. i am rather fair and a little of this goes a long way, so the smaller amount people are talking about here is really a non-issue for me. the shimmer is lovely and subtle. my main complaint is that the case broke so soon after i purchased this. i travel a lot for work and i have to leave this at home and keep it flat on a shelf as the top part of the compact (the mirror part) completely broke off. i read that bourjois eyeshadows and blushes are made by the manufacturers who make chanel, but i cannot confirm this.
Age: 19-24
Skin: Combination, Fair-Medium, Not Sure
Hair: Blond, Other, Other
Eyes: Blue
I love, love, love this gorgeous color! I love the small iridescent glitter amount. I would definitely repurchase it. I have to say, it's quite expensive for the small amount you get in the pot, but the color is unique.
Age: 19-24
Skin: Combination, Fair, Not Sure
Hair: Blond, Other, Other
Eyes: Blue
i bought this recently because I wanted to try a pink in a powder blush and bourjois is known for being good with brushes. Lately i've been using maybelline dream mousse in mauve (soft plum in the US), because cream or mousse blushes have been plauded for being better at achieving a natural effect than powder ones but, though i love the colour, i have found that the application is much harder and it's difficult to get the right amount of mousse onto the right part of your cheeks and sometimes with all that blending the oils on your finger start to take your foundation and powder off so it can end up looking wrong. Anyway it took me quite a while to decide which one to get either this one, rose d'or, or rose de jaspre. I'm very pale so thought that this as the lighter of the two shades would be better. It cost �6.25 on the expenseive side for a drugstore blush. the have to types of bluses, matt ones, or the ones with slight shimmer - they all have 'd'or' in the title, literally, of gold from French. Anyway this gives a lovely pink glow (v similar to maybelline's) and can be built up slowly. it is quite pigmented so watch out. As for the case, it's probably not the best design but i have a few of these little pots and they have never broken. oh , it does come with a tiny brush inside but I advise using a fullsize pro brush. all in all, happy with my purchase.
Age: 18 & Under
Skin: Combination, Fair-Medium, Not Sure
Hair: Brunette, Other, Other
Eyes: Brown
I really love this one, I love the subtle sparkles in it
Age: 19-24
Skin: Combination, Fair, Not Sure
Hair: Red, Other, Other
Eyes: Green
This is my go-to blush for day to day use. i find that a quick swipe of this leaves me with a very natural "rosy-cheeked" look, and it can be built up very easily for a more dramatic evening look, without ever looking clownish! when i wear this i look healthier, and i don't think its glaringly obvious that i'm wearing blusher at all because it looks so natural. i love the scent of this stuff too, not that it is particularly relevant! the only negative i have about this product - i have been using bourjois eyeshadows and blushers for years, and whilst the little round pots are cute, they always seem to end up breaking at the hinge or cracking, which is such a pain. i have a pile of about 6 of them on my shelf that can't go in my makeup bag because the pots are broken :(
Popular Blush Products
365 Reviews
20 Reviews
5200 Reviews
238 Reviews
266 Reviews
94 Reviews


text:
Things to see and do - Ascain
Leaving for France
Ascain :
Unmissable tourist site
Where to sleep?
Ascain Hotel tips
Hotel Alaïa from54 €Book
Hôtel Ilargi from50 €Book
Hôtel de la Rhune fromBook
Ascain Travel guide
Ascain : Michelin's recommendations
The village square is lined with traditional houses, whose red, green and blue shutters contrast with the whitewashed walls. A pelota court, a trinquet (covered pelota court) and a church with three tiered galleries and a massive belfry porch are among Ascain's attractions.
Tourist attractions Ascain : Things to see and do
La Rhune (in Basque larrun means good pasture land) is regarded as the symbol of the French Basque country. From the summit (900m) of the frontier-mountain there is a superb panorama over the ocean, the Landes Forest, the Basque Pyrenees and, southwa..
Hotels Ascain
Hôtel - Restaurant du Pont
Rd 918 F - 64310 Ascain
Prix Prices from : 41 €
The Hôtel Du Pont is located in the Basque countryside, outside the small town of Ascain. It has a shaded garden, terrace and en-suite guestrooms with TV. Free Wi-Fi is available on the ground floor. L'Hotel Du Pont is situated on the banks of the r..
Hôtel Ilargi
rue de la Cidrerie, Z.A de Lanzelaï F - 64310 Ascain
Located in the heart of the Basque Country 3 km from Ascain and 5 km Saint-Jean-de-Luz, Hôtel Ilargi is an environment friendly hotel offering rooms featuring a décor based on travel as well as self-catering accommodation. Hôtel Ilargi rooms are ind..
Hôtel de la Rhune
Place Pierre Loti F - 64310 Ascain
Hôtel De La Rhune is located in the historic centre of Ascain, 7 km from the Rhune Mountains. It offers guest rooms equipped with a flat-screen TV and private bathroom. A copious breakfast featuring local products is served every morning. There is a..


text: 70 Rally of Champions by Gary Grayson Best Sellers Trending Art Best Selling Art Prints Best Selling Abstract Art Prints Best Selling Photography Best Selling Posters Popular Subjects Animals Architecture Childrens Art Floral & Still Life Landscape Maps Military & War Music Science Fiction & Fantasy Skylines Spiritual Transportation Featured Artists Brickhut Cozamia Eric Joyner Erin Ashley Heron Dance James Niehues Jennifer Lommers Jonas Gerard Marcia Baldwin Mark Lawrence Michael Creese Michael Tompsett Starla Halfmann Collections ArtLoversOnline Design Pics The Fine Art Masters Panoramic Images Retro Images Archive StockTrek Images WorldWide Archive Create Your Own Photo Canvas Custom Frame Photos Rally of Champions by Gary Grayson (2012) Sign inCustomer Service Cart Houzz Share on Tumblr Tweet +Add to Cart Available Sizes inches / cm Petite $14.49 Small $15.99 Medium $18.99 Large $25.99 Grande $40.99 Massive $55.99 » component prices Print Frame Mats Glazing Fitting Customize Framing or choose Canvas Print Customize Canvas or choose Framed Art Print Click to save as artist's preferred kit Paper Enhanced MattePremium Photo GlossyPremium Photo LusterUltraSmooth Fine ArtHahnemuhle Photo Rag 308Hahnemuhle Fine Art PearlHahnemuhle Torchon Mounted? ★★★☆☆ Details Paper print only, too large to frame online. Frames Choose a color » ø Top Mat | Middle Mat | Bottom Mat ø Glazing Style Soft EdgeWhite EdgeBlack EdgeImage WrapUnstretched 1½ inches thick (3.75 cm) Product Details Artist grade canvas, archival inks, wooden stretcher bars, and UVB protective coating Availablity Usually ships within five business days. Artist Gary Grayson Platinum MemberCollection AntiqueDescription Vintage Movie Racing Poster Popular Configurations Stretched Canvas Modern Lines Contemporary White Classical Baroque Unframed print Explore More from the same collection View All Gary Grayson's Recent Work About the artist Gary Grayson, Arlington, Texas Member Since January 2012 Artist Statement Gary Grayson, a talented and versatile artist from Arlington, Texas, received his Bachelor of Fine Arts degree from University of Texas. He worked for over 30 years in advertising and graphic design, and as a successful freelance illustrator. In 1999, Gary opened Artefacts-Antiques.com, an art gallery showcasing his work and others, fulfilling a lifetime dream. His talents have been widely acclaimed and his work can be found in many private and corporate collections around the world. You can also purchase prints directly from Gary. If you would like to trade art prints please call 817-465-1833. http://society6.com/redssr03 http://www.cafepress.com/creativeartefacts http://pixels.com/profiles/gary-grayson.html http://gary-grayson.artistwebsites.com/index.html http://artefacts-antiqueimages.blogspot.com/ http://garypamtraveldiary.blogspot.com/ http://pinterest.com/redssrtruck/my-art/ http://www.zazzle.com/redssr2003 http://www.imagekind.com/artists/redssr03/Vintage/fine-art-prints When you purchase a piece of Gary's art, please send him your mailing address via email, so that he may send you an authentication certificate with his signature, that you can keep with the art for investment purposes. Community Comments Catalog Details Product No 4532231 Subjects Décor, Entertainment, Movies Style Decorative Medium Tags Gary, Grayson, Typographic, advertising, antique, decorative, design, digital, gary, graphic, grayson, illustration, interior, poster, product, travel, vector, vintage +Show Statistics Create Frame Photos Photos on Canvas Sell Sell Art Online Become an Affiliate Get a Trade Account Common Questions Company Info About Us Contact Customer Comments Return Policy Social Tumblr Pinterest Twitter Facebook Instagram Our Wall Art Family CanvasOnDemand | Photo Canvases GreatBigCanvas | Decorate Huge Terms of Service Privacy Policy Copyright © 2016


text:
Soft - Tan - Valentines Day - Bath Robes
+Quick Viewmore colors
+Quick Viewmore colors
+Quick View
Fri May 03 00:00:00 MDT 2013leslieadn Rating:5.0
Delivery was very fast as always with Overstock. The robe itself is quite beautiful and of very good quality. I have stayed in many luxury hotels who had robes exactly like this one and it is difficult to see any difference in the quality. I ordered a L/XL and it is a nice, slightly oversized fit (probably good for women sized 10-16), just above the ankles with slightly long sleeves that can be rolled. Very soft inside and out, cream color that has a tan/yellow hue which is a nice contrast with the white interior. Very glad that I ordered this one instead of the one I saw on another website for $95!
Fri Feb 18 00:00:00 MST 2011pizziehl Rating:4.0
My boyfriend really wanted a bathrobe for Valentine's Day that was terry which is getting harder to find. Unless you have overstock!! The robe is a little big, super soft, but not that thick (hence the 4 stars).
Mon Mar 01 00:00:00 MST 2010hopper720 Rating:5.0
I ordered these robes for valentines day. Very soft, comfortable and warm. Great quality for the price!
Wed Jan 07 00:00:00 MST 2015saltfish Rating:5.0
This robe is very soft, nice size to accomodate different body sizes and shapes. I ordered it in tan and it is true to the picture on the net.
Thu Feb 11 00:00:00 MST 2010hdavid35 Rating:5.0
Thiis is a great robe at a greaT price. Very soft and comfortable. We use them in a tanning salon so they get used and abused a lot. Best robe I have found yet.
A quality bathrobe can quickly become your favorite wardrobe item. The right robe will wrap you in luxury and warmth that can start your day off on the right foot or end your day on the right note. Robes made from top-quality materials can last you for years, so it's important to find one that you know you will like before you invest. Keep reading for tips on choosing the perfect robe for you. Buying Bath Robes: Shop Bathrobes ▸ The Difference Between Egyptian and Turkish Cotton You may notice that a lot of bathrobes feature either Egyptian cotton or Turkish cotton fibers. Read More
Shop Overstock™ and find the best online deals on everything for your home and your family. We work every day to bring you discounts on new products across our entire store. Whether you're looking for memorable gifts or everyday essentials, you can buy them here for less. Not just anyone's mobile outlet, your mobile outlet.O.com ® The O at Home ®


text: Comments (1) + Add comment Comments (1) Featured Wni0 + 937d ago Take it back!!! Condemned Criminal Origins is still the best horror game, easily as good as fucking cod2. #1 Agree(0) | Disagree(0) | Report | Reply Add comment You need to be registered to add comments. Register here or login Username Password Remember Rules & guidelines Login